Monthly Archives: September 2015

Real World Evidence Making Headlines

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

50% of real-world studies started in the last 3 years
RWE roundup – December 2018
Unique real-world study in diabetic macular oedema (DMO)
First real-world multicentre study of the use of inhaled aztreonam lysine for cystic fibrosis (CF)
DESERVE showed significant benefits in NHS healthcare savings

Quick Links

Real World Evidence
Global Real World Evidence
Additional Services
Privacy Policy
Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

+44 (0)1252 417030

Quick Links

Real World Evidence
Global Real World Evidence
Additional Services
Privacy Policy
Contact Us

Twitter

Tweets by @SVMPharma

Latest News

Alunbrig recommended by NICE for non-small-cell lung cancer February 15, 2019
Trajenta meets primary endpoint in CAROLINA trial February 15, 2019
Could AI predict survival of ovarian cancer patients? February 15, 2019
NICE changes its mind on Perjeta February 15, 2019
New Academy launched to fight osteoporosis February 15, 2019

Privacy Policy
Website Disclaimer
Sitemap